Management of Dyslipidemia

Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapte...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Aineistotyyppi: Online
Kieli:englanti
Julkaistu: IntechOpen 2023
Aiheet:
Linkit:ONIX_20231201_9781839685088_2064
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
_version_ 1869529347621126144
collection Directory of Open Access Books
description Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.
format Online
id doab-20.500.12854ir-130954
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-1309542024-03-31T22:44:05Z Management of Dyslipidemia Aronow, Wilbert S. cardiovascular disease, statins, familial hypercholesterolemia, covid-19, diabetes, atherosclerosis thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood. 2023-12-01T18:33:50Z 2023-12-01T18:33:50Z 2021 book ONIX_20231201_9781839685088_2064 9781839685088 9781839685071 9781839685095 https://directory.doabooks.org/handle/20.500.12854/130954 eng image/jpeg n/a https://www.intechopen.com/books/9496 https://mts.intechopen.com/storage/books/9496/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.87280 10.5772/intechopen.87280 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839685088 9781839685071 9781839685095 IntechOpen 174 open access
spellingShingle cardiovascular disease, statins, familial hypercholesterolemia, covid-19, diabetes, atherosclerosis
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
Management of Dyslipidemia
title Management of Dyslipidemia
title_full Management of Dyslipidemia
title_fullStr Management of Dyslipidemia
title_full_unstemmed Management of Dyslipidemia
title_short Management of Dyslipidemia
title_sort management of dyslipidemia
topic cardiovascular disease, statins, familial hypercholesterolemia, covid-19, diabetes, atherosclerosis
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
topic_facet cardiovascular disease, statins, familial hypercholesterolemia, covid-19, diabetes, atherosclerosis
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
url ONIX_20231201_9781839685088_2064